Cover Image
市場調查報告書

伊文氏肉瘤:全球臨床實驗回顧

Ewing Sarcoma Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 230804
出版日期 內容資訊 英文 208 Pages
訂單完成後即時交付
價格
Back to Top
伊文氏肉瘤:全球臨床實驗回顧 Ewing Sarcoma Global Clinical Trials Review, H1, 2016
出版日期: 2016年05月19日 內容資訊: 英文 208 Pages
簡介

本報告提供全球伊文氏肉瘤治療藥物的臨床實驗的相關調查,各地區臨床實驗數資料,實驗階段,實驗情形,採用題目及各類型贊助企業的臨床實驗資料,中斷(暫時停止,廢止,停止)的實驗清單等資料,為您概述為以下內容。

目錄

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 伊文氏肉瘤
  • 報告指南
  • 臨床實驗 , 各地區
  • 臨床實驗 , 各國
  • 對臨床實驗有所貢獻的前幾名國家 - 亞太地區
  • 對臨床實驗有所貢獻的前五國 - 歐洲
  • 對臨床實驗有所貢獻的前幾名國家 - 北美
  • 對臨床實驗有所貢獻的前幾名國家 - 中東及非洲
  • 對臨床實驗有所貢獻的前幾名國家 - 中南美
  • 臨床實驗 金磚四國 各國
  • 臨床實驗 G7 各國
  • 臨床實驗 - G7 各國 , 各臨床實驗狀態
  • 臨床實驗 E7 各國
  • 臨床實驗 - E7 各國 , 各臨床實驗狀態
  • 臨床實驗 各階段
  • 進行中的臨床實驗 各階段
  • 臨床實驗 , 各臨床實驗狀態
  • 每段時期的實驗人數
  • 有力的贊助商
  • 前幾名參與企業 - 伊文氏肉瘤 治療藥物的臨床實驗
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 前幾名企業
  • Pfizer Inc.
  • 臨床實驗概要; Pfizer Inc.
  • PharmaMar, S.A.
  • 臨床實驗概要; PharmaMar, S.A.
  • Jennerex Biotherapeutics, Inc.
  • 臨床實驗概要; Jennerex Biotherapeutics, Inc.
  • 第一三共
  • 臨床實驗概要; 第一三共
  • Oncolytics Biotech Inc.
  • 臨床實驗概要; Oncolytics Biotech Inc.
  • Merck & Co., Inc.
  • 臨床實驗概要; Merck & Co., Inc.
  • Eli Lilly and Company
  • 臨床實驗概要; Eli Lilly and Company
  • Amgen Inc.
  • 臨床實驗概要; Amgen Inc.
  • Genzyme Corporation
  • 臨床實驗概要; Genzyme Corporation
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Stanford University
  • 臨床實驗概要; Stanford University
  • The University of Texas M. D. Anderson Cancer Center
  • 臨床實驗概要; The University of Texas M. D. Anderson Cancer Center
  • St. Jude Children's Research Hospital, Inc.
  • 臨床實驗概要; St. Jude Children's Research Hospital, Inc.
  • Emory University
  • 臨床實驗概要; Emory University
  • University of Munster
  • 臨床實驗概要; University of Munster
  • City of Hope National Medical Center
  • 臨床實驗概要; City of Hope National Medical Center
  • Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
  • 臨床實驗概要; Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
  • Sarcoma Alliance for Research through Collaboration
  • 臨床實驗概要; Sarcoma Alliance for Research through Collaboration
  • St. Orsola Hospital
  • 臨床實驗概要; St. Orsola Hospital
  • Institut Curie
  • 臨床實驗概要; Institut Curie
  • Mayo Clinic
  • 臨床實驗概要; Mayo Clinic
  • Institut Gustave Roussy
  • 臨床實驗概要; Institut Gustave Roussy
  • Memorial Sloan Kettering Cancer Center
  • 臨床實驗概要; Memorial Sloan Kettering Cancer Center
  • Fred Hutchinson Cancer Research Center
  • 臨床實驗概要; Fred Hutchinson Cancer Research Center
  • National Cancer Center
  • 臨床實驗概要; National Cancer Center
  • Five 主要 臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

表格一覽

  • 伊文氏肉瘤 全球治療藥物市場, 臨床實驗 各地區
  • 伊文氏肉瘤 全球治療藥物市場, 臨床實驗 , 各國排名
  • 伊文氏肉瘤 全球治療藥物市場, 進行中的臨床實驗 , 各國排名
  • 伊文氏肉瘤 治療藥物的臨床實驗, 亞太地區, 前幾名國家
  • 伊文氏肉瘤 治療藥物的臨床實驗, 歐洲, 前五國
  • 伊文氏肉瘤 治療藥物的臨床實驗, 北美, 前幾名國家
  • 伊文氏肉瘤 治療藥物的臨床實驗, 中東及非洲, 前幾名國家
  • 伊文氏肉瘤 治療藥物的臨床實驗, 中南美, 前幾名國家
  • 伊文氏肉瘤 治療藥物的臨床實驗, 金磚四國 各國
  • 伊文氏肉瘤 治療藥物的臨床實驗, G7 各國
  • 伊文氏肉瘤 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 伊文氏肉瘤 治療藥物的臨床實驗, E7 各國
  • 伊文氏肉瘤 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 伊文氏肉瘤 全球治療藥物市場, 臨床實驗 各階段
  • 伊文氏肉瘤 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 伊文氏肉瘤 全球治療藥物市場, 臨床實驗 , 各臨床實驗狀態
  • 伊文氏肉瘤 全球治療藥物臨床實驗, 平均登錄對像人數趨勢
  • 伊文氏肉瘤 全球治療藥物臨床實驗, 主要的贊助商
  • 伊文氏肉瘤 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 伊文氏肉瘤 全球治療藥物臨床實驗, 臨床實驗, 各有潛力治療藥
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Pfizer Inc.
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- PharmaMar, S.A.
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Jennerex Biotherapeutics, Inc.
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- 第一三共
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Oncolytics Biotech Inc.
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Merck & Co., Inc.
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Eli Lilly and Company
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Amgen Inc.
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Genzyme Corporation
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Stanford University
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- The University of Texas M. D. Anderson Cancer Center
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- St. Jude Children's Research Hospital, Inc.
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Emory University
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- University of Munster
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- City of Hope National Medical Center
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Sarcoma Alliance for Research through Collaboration
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- St. Orsola Hospital
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Institut Curie
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Mayo Clinic
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Institut Gustave Roussy
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Memorial Sloan Kettering Cancer Center
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- Fred Hutchinson Cancer Research Center
  • 伊文氏肉瘤 全球治療藥物臨床實驗市場, 臨床實驗- National Cancer Center

圖表一覽

圖表一覽

  • 伊文氏肉瘤 全球治療藥物市場, 臨床實驗 各地區 (%)
  • 伊文氏肉瘤 全球治療藥物市場, 臨床實驗 , 各國排名
  • 伊文氏肉瘤 全球治療藥物市場, 進行中的臨床實驗 , 各國排名
  • 伊文氏肉瘤 治療藥物的臨床實驗, 亞太地區, 前幾名國家 (%)
  • 伊文氏肉瘤 治療藥物的臨床實驗, 歐洲, 前五國 (%)
  • 伊文氏肉瘤 治療藥物的臨床實驗, 北美, 前幾名國家 (%)
  • 伊文氏肉瘤 治療藥物的臨床實驗, 中南美, 前幾名國家 (%)
  • 伊文氏肉瘤 治療藥物的臨床實驗, G7 各國 (%)
  • 伊文氏肉瘤 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 伊文氏肉瘤 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 伊文氏肉瘤 全球治療藥物市場, 臨床實驗 各階段 (%)
  • 伊文氏肉瘤 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 伊文氏肉瘤 全球治療藥物市場, 臨床實驗 , 各臨床實驗狀態
  • 伊文氏肉瘤 全球治療藥物臨床實驗, 平均登錄對像人數趨勢
  • 伊文氏肉瘤 全球治療藥物臨床實驗, 主要的贊助商
  • 伊文氏肉瘤 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 伊文氏肉瘤 全球治療藥物臨床實驗, 臨床實驗, 各有潛力治療藥
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3409CTIDB

GlobalData's clinical trial report, "Ewing Sarcoma Global Clinical Trials Review, H1, 2016" provides an overview of Ewing Sarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Ewing Sarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Ewing Sarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Ewing Sarcoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Ewing Sarcoma Therapeutics, Global, Clinical Trials by Region, 2016*
  • Ewing Sarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Ewing Sarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*
  • Proportion of Ewing Sarcoma to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Ewing Sarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Ewing Sarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Ewing Sarcoma to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Ewing Sarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Ewing Sarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Ewing Sarcoma Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Ewing Sarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Ewing Sarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Ewing Sarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Ewing Sarcoma Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Ewing Sarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Ewing Sarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016*
  • Proportion of Ewing Sarcoma to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Ewing Sarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Ewing Sarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Ewing Sarcoma to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Ewing Sarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Ewing Sarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Ewing Sarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Ewing Sarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Ewing Sarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Ewing Sarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Ewing Sarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top